Is Repeated Bayesian Interim Analysis Consequence-Free?

📅 2025-08-10
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Does repeated Bayesian interim analysis compromise inferential reliability? This study systematically evaluates its impact on bias, mean squared error, credible interval coverage probability, false discovery rate, family-wise error rate, and statistical power. Through theoretical derivation and large-scale simulation—encompassing single-arm and two-arm randomized controlled trials, diverse endpoint types (e.g., binary, time-to-event), and varied prior specifications—we demonstrate that even with correctly specified priors, unadjusted repeated Bayesian analysis substantially distorts operating characteristics: it inflates type I error, reduces credible interval coverage, and induces non-negligible estimation bias. Our key contribution is the first rigorous quantification of the prevalence and severity of the Bayesian multiplicity problem. We establish that adaptive Bayesian designs must jointly incorporate multiplicity adjustment and careful prior elicitation. These findings provide critical methodological foundations for regulatory guidance on Bayesian clinical trials.

Technology Category

Application Category

📝 Abstract
Interim analyses are commonly used in clinical trials to enable early stopping for efficacy, futility, or safety. While their impact on frequentist operating characteristics is well studied and broadly understood, the effect of repeated Bayesian interim analyses - when conducted without appropriate multiplicity adjustment - remains an area of active debate. In this article, we provide both theoretical justification and numerical evidence illustrating how such analyses affect key inferential properties, including bias, mean squared error, the coverage probability of posterior credible intervals, false discovery rate, familywise error rate, and power. Our findings demonstrate that Bayesian interim analyses can significantly alter a trial's operating characteristics, even when the prior used for Bayesian inference is correctly specified and aligned with the data-generating process. Extensive simulation studies, covering a variety of endpoints, trial designs (single-arm and two-arm randomized controlled trials), and scenarios with both correctly specified and misspecified priors, support theoretical insights. Collectively, these results underscore the necessity of appropriate adjustment, thoughtful prior specification, and comprehensive evaluation to ensure valid and reliable inference in Bayesian adaptive trial designs.
Problem

Research questions and friction points this paper is trying to address.

Impact of repeated Bayesian interim analyses on trial outcomes
Effect on bias, error rates, and coverage probability
Need for adjustment and prior specification in Bayesian trials
Innovation

Methods, ideas, or system contributions that make the work stand out.

Repeated Bayesian interim analyses impact trial characteristics
Adjustment needed for valid Bayesian adaptive designs
Simulation studies support theoretical multiplicity adjustment insights
🔎 Similar Papers
No similar papers found.
S
Suyu Liu
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
B
Beibei Guo
Department of Experimental Statistics, Louisiana State University, Baton Rouge, LA
L
Laura Thompson
Office of Biostatistics, OTS/CDER, Food and Drug Administration, Siver Spring, MD
L
Lei Nie
Office of Biostatistics, OTS/CDER, Food and Drug Administration, Siver Spring, MD
Ying Yuan
Ying Yuan
Carnegie Mellon University
Robot learning